TCTR20170811002已完成4 期
Pulse-dyed laser as an adjuvant treatment for papulopustular eruption due to epidermal growth factor receptor (EGFR) inhibitors
Quality Improvement Fund, King Chulalongkorn Memorial Hospital0 个研究点目标入组 15 人开始时间: 2017年8月11日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 0 N/A (No limit)（—）
- 性别
- All
入选标准
- •1. Males or females whose age are at least 18 years
- •2. Subjects who developed papulopustular eruption after EGFRIs initiation
- •3. Papaulopustular eruption severity of grade 1 2a or 2b (revised grading system based on National Cancer Institute Common Toxicity Criteria version 3)
- •4. Subjects who take EGFRIs throughout the research
- •5. Subjects who are able to avoid from sunlight exposure
- •6. Subjects who have signed consent form
排除标准
- •1. Males or females whose age are less than 18 years
- •2. Subjects who are currently pregnant or expecting
- •3. Subjects who are currently breastfeeding
- •4. Subjects who have done chemical peeling, lasers or IPL on the area of research interest (face) within the past 3 months before the enrollment
- •5. Subjects who have history of skin condition such as active skin diseases, skin infection on the area of research interest, which might affect either the treatment or the outcome evaluation.
- •6. Subjects who have history of skin cancers on the area of research interest
- •7. Subjects who have history of photosensitivity
- •8. Subjects who have history of abnormal bleeding or coagulation
- •9. Subjects who have history of delayed wound healing or abnormal scar formation on the area which might affect either the treatment or the outcome evaluation.
- •10. Subjects who have condition which might affect data collection and outcome evaluation or poses a potential risk to the subjects themselves. (Assessment by investigators or specialized physicians)
- •11. Subjects who are not qualified or unwilling to abide by the recruitment criteria
- •12. Subjects who are currently participating in other clinical interventions or using an unapproved or developing medical equipments/devices.
研究者
相似试验
已完成
3 期
Pulsed-dye laser as an adjuvant intervention to comedones treatment: A randomized controlled trialErythema index caused by comedone extraction after pulsed-dye laser treatmentpulsed-dye laser, comedone extraction, erythema, acneTCTR20190426001Ratchadapiseksompotch Fund35
已完成
不适用
Is the pulsed dye laser an effective adjuvant to topical therapy for psoriatic plaques?ISRCTN28336586Record Provided by the NHSTCT Register - 2006 Update - Department of Health20
已完成
不适用
safe laser therapy for intraretinal bleedingCTRI/2019/03/017901V Prasad Eye Institute11
已完成
4 期
The efficacy of pulsed-dye laser in the treatment of post-mastectomy hypertrophic scar and keloid in transmen population: A randomized controlled trial studyHypertrophic or keloidal mastectomy scars595-nm pulsed dye laser, female-to-male transgender, hypertrophic scars, keloids, post-mastectomy, transmenTCTR20230304002Division of Dermatology, Department of medicine, Faculty of Medicine, Ramathibodi hospital25
已完成
不适用
Diffuse laser treatment for prophylaxis of the fellow eye with age-related maculopathy in patients with exudative age-related macular degeneration (AMD)ISRCTN74548520Record Provided by the NHSTCT Register - 2006 Update - Department of Health